XP Chemistries AB (XPC) - Total Liabilities
Based on the latest financial reports, XP Chemistries AB (XPC) has total liabilities worth Skr1.09 Million SEK (≈ $117.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore XPC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
XP Chemistries AB - Total Liabilities Trend (2019–2024)
This chart illustrates how XP Chemistries AB's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does XP Chemistries AB generate to measure how efficiently the company converts operating cash flow to free cash.
XP Chemistries AB Competitors by Total Liabilities
The table below lists competitors of XP Chemistries AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eastfield Resources Ltd
V:ETF
|
Canada | CA$88.52K |
|
Cerillion PLC
LSE:CER
|
UK | GBX15.33 Million |
|
2CUREX AB SEK-10
F:2QE
|
Germany | €4.55 Million |
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
USA | $7.40 Million |
|
Xamble Group Ltd
AU:XGL
|
Australia | AU$3.45 Million |
|
Airtouch Solar Ltd
TA:ARTS
|
Israel | ILA22.97 Million |
|
Frp Advisory Group Plc
LSE:FRP
|
UK | GBX63.10 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down XP Chemistries AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see XP Chemistries AB market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 18.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how XP Chemistries AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for XP Chemistries AB (2019–2024)
The table below shows the annual total liabilities of XP Chemistries AB from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr1.16 Million ≈ $124.31K |
-23.39% |
| 2023-12-31 | Skr1.51 Million ≈ $162.26K |
-4.73% |
| 2022-12-31 | Skr1.58 Million ≈ $170.31K |
-48.83% |
| 2021-12-31 | Skr3.09 Million ≈ $332.85K |
+388.12% |
| 2020-12-31 | Skr633.64K ≈ $68.19K |
-- |
| 2019-12-31 | Skr0.00 ≈ $0.00 |
-- |
About XP Chemistries AB
XP Chemistries AB (publ), a biotechnology company, engages in the development and production of forest-based capsaicin and analogues. It offers animal feed ingredients; personal care and cosmetic ingredients; pure capsaicinoids; and self-defense spray ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.